Evidence map›Paper›PMID 26525047›Full record

ArticleJournal of cardiovascular translational research2015

Panax Notoginseng Saponins Ameliorates Coxsackievirus B3-Induced Myocarditis by Activating the Cystathionine-γ-Lyase/Hydrogen Sulfide Pathway.

Lulu Pan, Yuanhai Zhang, Jiacheng Lu, Zhimin Geng, Lianhong Jia, Xing Rong, Zhenquan Wang, Qifeng Zhao, Rongzhou Wu, Maoping Chu and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of cardiovascular translational research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Efficacy and safety ofFrontiers in pharmacology · 2024
    Pooled it
  2. Review
  3. Review
  4. Antiviral Potential of the GenusJournal of ginseng research · 2023
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Lulu PanChildren's Heart Center, The Second Affiliated Hospital & Yuying Children's Hospital, Institute of cardiovascular development and translational medicine, Wenzhou Medical University, Wenzhou, 325027, China.
Yuanhai ZhangChildren's Heart Center, The Second Affiliated Hospital & Yuying Children's Hospital, Institute of cardiovascular development and translational medicine, Wenzhou Medical University, Wenzhou, 325027, China.
Jiacheng LuChildren's Center, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325000, China.
Zhimin GengChildren's Center, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325000, China.
Lianhong JiaChildren's Center, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325000, China.
Xing RongChildren's Heart Center, The Second Affiliated Hospital & Yuying Children's Hospital, Institute of cardiovascular development and translational medicine, Wenzhou Medical University, Wenzhou, 325027, China.
Zhenquan WangChildren's Heart Center, The Second Affiliated Hospital & Yuying Children's Hospital, Institute of cardiovascular development and translational medicine, Wenzhou Medical University, Wenzhou, 325027, China.
Qifeng ZhaoChildren's Heart Center, The Second Affiliated Hospital & Yuying Children's Hospital, Institute of cardiovascular development and translational medicine, Wenzhou Medical University, Wenzhou, 325027, China.
Rongzhou WuChildren's Heart Center, The Second Affiliated Hospital & Yuying Children's Hospital, Institute of cardiovascular development and translational medicine, Wenzhou Medical University, Wenzhou, 325027, China.
Maoping ChuChildren's Heart Center, The Second Affiliated Hospital & Yuying Children's Hospital, Institute of cardiovascular development and translational medicine, Wenzhou Medical University, Wenzhou, 325027, China. chmping@126.com.
Chunxiang ZhangChildren's Heart Center, The Second Affiliated Hospital & Yuying Children's Hospital, Institute of cardiovascular development and translational medicine, Wenzhou Medical University, Wenzhou, 325027, China. chunxiang_zhang@rush.edu.
Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University · CNWenzhou Medical University · CN

Funding

Circulating cell-free microRNAs in atherogenesisR21HL109656 · NHLBI · RUSH UNIVERSITY MEDICAL CENTER · PI ZHANG, CHUNXIANG · 2012 to 2013
$410k
MicroRNA mechanism and therapeutics of impaired wound healingR21NR013876 · NINR · RUSH UNIVERSITY MEDICAL CENTER · PI ZHANG, CHUNXIANG · 2012 to 2013
$409k
NHLBI NIH HHS HL109656NHLBI NIH HHS R21 HL109656NINR NIH HHS NR013876NINR NIH HHS R21 NR013876
6 · The paper itself

Abstract

This study is to determine the therapeutic effects of Panax notoginseng saponins (PNSs) on coxsackievirus B3 (CVB3)-induced myocarditis, and whether cystathionine-γ-lyase (CSE)/hydrogen sulfide (H2S) pathway is involved. Mouse model of myocarditis was induced by CVB3 infection, and the mice were subjected to vehicle (saline) or drug treatments (sodium bisulfide (NaHS), propargylglycine (PAG), or PNSs). The results showed that there were inflammatory cell infiltrations, interstitial edemas, and elevated inflammatory cytokines, in CVB3-induced myocarditis. PAG administration increased, whereas NaHS treatment decreased the severity of the myocarditis. PNS treatment dramatically alleviated these myocardial injuries and decreased the viral messenger RNA (mRNA) expression by the enhanced expression of CSE/H2S pathway. Moreover, the therapeutic effects of PNSs on myocarditis were stronger than those of NaHS. Finally, the effect of PNSs on CSE/H2S pathway and cardiac cell protection were verified in cultured cardiac cells. PNSs may be a promising medication for viral myocarditis therapy.

Indexed as

Panax notoginsengAnalysis of VarianceAnimalsBiomarkersBlotting, WesternCoxsackievirus InfectionsCystathionine gamma-LyaseDisease Models, AnimalEnterovirus B, HumanEnzyme-Linked Immunosorbent AssayHumansHydrogen SulfideMaleMiceMice, Inbred BALB CMyocarditisBiomarkersCystathionine gamma-LyaseHydrogen SulfidePlant PreparationsRNA, Small InterferingSaponinsCystathionine-γ-lyaseHydrogen sulfideMyocarditisPanax notoginseng saponins

Identifiers

PMID26525047
PMCPMC4674358
OpenAlexW1940235456

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.